Among these, RAD51C was found constitutively hypermethylated in sporadic BC, as showed by Hansmann and colleagues [10], who identified hypermethylation at both BRCA1 and RAD51C promoters in 1.4% and 0.5% of high-risk cancer patients, respectively. Here, RAD51C is linked to breast cancer.